Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Dizziness

glucose, (beta-d)-isomer has been researched along with Dizziness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobbins, RL; Hompesch, M; Hussey, EK; James, CD; Kapur, A; Mikoshiba, I; Nunez, DJ; O'Connor-Semmes, R; Polli, JW; Smith, GA; Tao, W1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Dizziness

ArticleYear
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus.
    BMC pharmacology & toxicology, 2013, May-13, Volume: 14

    Topics: Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Electrolytes; Female; Glucosides; Headache; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Molecular Structure; Pyrazoles; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome

2013